Director, President and CEO · ENANTA PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$67K
Shares
4,743
Price
$14.23
Executed
Dec 5, 2025
Disclosed
Dec 5, 2025
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Dec 5 executedDec 5, 2025 disclosed
ENTA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
6 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Luly Jay R. filed this Form 4 reporting a open-market sale of ENTA on Dec 5, 2025. It became public on Dec 5, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Luly Jay R.cik:0001571211
Issuer
ENANTA PHARMACEUTICALS INCcik:0001177648
Revision history · 0
No field has changed since this record was first ingested.
